03.07.2019

Reason to Celebrate – CorTec received TOP 100 Award

On the evening of 28 June 2019, CEO, Dr. Jörn Rickert and Dr. Christina Schwartz received CorTec’s “TOP 100” award at the Jahrhunderthalle in Frankfurt. CorTec was ranked among the 10 best companies.

For the 26th time, the most innovative companies in Germany were honoured. On the basis of scientific systematics, TOP 100 evaluates the innovation management of medium-sized companies.

 

We are very pleased about the award and the confidence in our innovative strength.

Special thanks go to our strong team for the outstanding achievements that made this award possible.

 

Find out more about TOP 100 and the selection process here.

07.05.2019

CorTec Receives Freiburg Innovation Award

As one of five companies, CorTec was awarded the Freiburg Innovation Prize by the Technology Foundation Bio-Med Freiburg.

Bio-Med Freiburg has been awarding the prize every two years since 1992 in cooperation with the medical technology company Stryker and the bank Sparkasse Freiburg-Nördlicher Breisgau. The companies that received the award in this year’s edition are active in the fields of medical technology, chemistry, software and green energy.

20.03.2019

First CorTec Product Receives FDA Clearance

The °AirRay Cortical Electrode is CorTec’s first medical device to receive market clearance from the Food and Drug Administration (FDA) in the USA for invasive neuromonitoring in the central nervous system. It can now be used as a diagnostic aid, for example before brain surgery.

“For us as a company, the market clearance of our AirRay electrodes is an important milestone,” said Dr. Jörn Rickert, Chief Executive Officer of CorTec. “lt shows to us and to our customers that we have been working in the right direction. Together with our new premises, including our own production facility we are now ideally positioned as a partner for the development of innovative neurotherapies.”

Some brain diseases may require surgical resection of the affected parts of the brain. AirRay Cortical Electrode is used for invasive neuromonitoring which comprises recording and stimulation of brain activity from the cortical surface over a period of time. In order to precisely locate diseased brain tissue such as epileptogenic foci or brain tumors while protecting healthy areas responsible for important brain functions, the brain must be ‘mapped’ prior to surgery. The electrode may be used for up to 29 days.

CorTec introduces several innovations into this long-established method of treatment. The planar grid and strip electrodes are produced in a proprietary laser-assisted manufacturing process. This results in a very soft, thin, and flexible electrode that adapts well to the curved surface of the brain.

In combination with new analytical methods AirRay Cortical Electrode may enable shorter surgery durations and more precise diagnostics in the future: For example with the aid of automated mapping of the brain in real-time, as enabled by the CortiQ system from g.tec (Austria), it will be possible to locate functional brain areas faster and more reliably in the future.  A research group led by Nuri F. lnce at the University of Houston, Texas, is investigating high-frequency oscillations in brain activity as biomarkers for a more precise determination of epileptogenic foci. “Regulatory approval of CorTec’s AirRay Cortical Electrode opens up exciting new options both in clinical applications and in research using intracranial recording and stimulation methods,” commented neuroscientist Dr. Gerwin Schalk, Chair of the International Workshop on Advances in Electrocorticography series and Deputy Director of the National Center for Adaptive Neurotechnologies in Albany.

The product also contains important safety features. “Health and well-being of the patient are of the utmost importance to us. Therefore, we emphasize safe electrode design,” said Dr. Martin SchĂŒttler, Chief Technology Officer and also Chief Executive Officer of CorTec. °AirRay Cortical Electrode has an even surface with individual electrode contacts almost being impalpable. Additionally, to prevent the contacts from dislocating or detaching from the silicone carrier material each contact safely interlocks with the material.

CorTec plans to market the AirRay Cortical Electrode through distribution partners. Corresponding contracts are currently in preparation.

Learn more about °AirRay Cortical Electrode

Download the press release on the market clearance of °AirRay Cortical Electrode

 

[1] See the publication by S. Liu et al., Brain 2018, 1, doi:10.1093/brain/awx374

14.03.2019

Meet Us at IEEE Neural Engineering!

Meet us at the 9th International IEEE EMBS Conference on Neural Engineering focussing on “Neurotechnologies for Medical Therapies and Beyond” taking place from March 20-23 in San Francisco.
CTO and CEO, Dr. Martin SchĂŒttler, will give a talk about ‘Focus on Neural interface and Electrode Technologies’ at the IEEE NeuroTech Entrepreneurship and Innovation Workshop on March 20th during Symposium#2: Neural Probes, Interface and Electrode, Orthopedics Technologies between 11am and 12:30pm.

21.02.2019

CorTec Is Chosen Innovator 2019 by brand eins and Statista

Just like last year CorTec has made it to the list of the most innovative companies selected by German business journal brand eins and Statista. Together with 16 other companies in the medical devices industry CorTec may now bear the title “Innovator 2019”.

Experts from the Institute for Innovation an Technology (iit) in Berlin and from the Statista panel „Expert Circle“ as well as leading business representatives from innovation award-winning companies have assessed more than 2,000 companies from 20 industries this year. Other companies in the “Medical Devices and Products” / “Medizinische GerĂ€te und Produkte” industry that are acclaimed alongside CorTec are for example Otto Bock Healthcare, Medtronic, Siemens Healthcare, Heraeus or Med-El.

“The renewed distinction as one of the most innovative companies is a great honor for us, especially as it reflects the consistency in our development as a company over the last years,” said Dr. Jörn Rickert, Chief Executive Officer of CorTec. “After moving to our new facilities and bringing the human version of our Brain Interchange system into operation we still see high potential to boost our innovative capabilities,” added Dr. Martin SchĂŒttler, Chief Technology Officer and Chief Executive Officer of CorTec. “We are just at the beginning.”

CorTec is positioning itself with its Brain Interchange technology as a partner for the development of innovative neurotherapies. First customers are using the closed-loop system already for pre-clinical research. The first human use of the system for exploring new personalized therapies for diseases like chronic pain, stroke, or Parkinson’s disease is about to follow as soon as possible.

CorTec is partnering up with researchers, clinicians, or other companies providing knowhow and technology to enable the development of next generation neuortherapies.

Learn more about the most innovative companies in Germany

Learn more about CorTec Brain Interchange

17.01.2019

Meet Us at NANS

The annual meeting of the North American Neuromodulation Society (NANS) starts today in Las Vegas focussing on “The Science Behind Successful Outcomes.”

CorTec will be represented with a poster. Check out the poster monitors to learn more about our AirRay electrode technology as well as about CorTec Brain Interchange, our closed loop implant system.

Learn more about NANS

09.01.2019

First Electrode Produced in New Facilities

We have started operations in our new offices in August. By the end of the year also our new manufacturing facility has been complete.

We are now in the process of qualifying the cleanroom. In the course of this process the first electrode has just been produced. A lot more are about to come…

20.12.2018

CorTec wishes happy holidays!

The CorTec deer has already prepared for the holiday season.

We are taking a short break, but will be back at the beginning of the new year to support you and your projects also in 2019.

We hope you are going to have some sparkling holidays just like our deer.

Merry Christmas & a Happy New Year!

25.10.2018

Meet Us at Neuroscience and Compamed!

As every year, we are exhibiting at the annual meeting of the Society for Neuroscience which takes place from November 4-7 at the San Diego Convention Center this year. Visit us at booth no. 3816.

Prior to the conference you already have the chance to meet us on November 1 and 2 at the IEEE Brain Initiative Workshop on Advanced NeuroTechnologies at the Hilton Bayfront Hotel in San Diego.

From November 12-15 we are the Compamed in DĂŒsseldorf, Germany. We are happy to welcome you at booth no. H29.1 in hall 8a.

We are happy to make an appointment with you in advance. Please call us (+49 761 70 888 222) or send us an email (sales@cortec-neuro.com) to arrange the appointment.

23.10.2018

CorTec is on the Way to the MRI compatible Implant

As active implants are dynamically spreading, also the requirements towards their MRI compatibility are increasing constantly. In the framework of the new funding project MR-Implant CorTec is developing new solutions for MRI compatible implants together with the Universtiy of Ulm, the Max Planck Institute for Biological Cybernetics and the company eesy-ic as project partners.

More and more patients receive active implants like cardiac pacemakers, neurostimulators, medication pumps etc. while MRI examinations are becoming the medical standard procedure for an increasing number of indications. At the same time most of the active implants are not or only with strong limitations MRI compatible.

With its Smart Health Initiative the German Federal Ministry of Education and Research (Bundesministerium fĂŒr Bildung und Forschung, BMBF) faces the challenge to promote innovations in the filed of medical engineering which meet the requirements of patients and medical care systems in the future. The funding program supports the MR-Implant consortium until the year of 2021 to develop new solutions for the MRI compatibility of active implants.

The project which is coordinated by CorTec aims at developing active implant systems which are able to exchange data at high speed, to record as well as to stimulate neural activity while enabling interference-free MRI examinations at the same point in time. The measured data of the implant can then be compared with the results of MRI examination. This way a more precise calibration of the implant system shall be possible as well as an improved therapy which adapts to the momentary needs of the individual patient.

“The possibility to conduct MRI examinations while the implant is operating is extremely advantageous in clinical practice,” said Prof. Dr. Ulf Ziemann, chairman of the Department of Neurology and Stroke at University Hospital TĂŒbingen and member of CorTec’s Scientific Technical Advisory Board. “Being able to precisely locate electrical brain signals enables us to synchronize the placement of the implant with the individual patient’s anatomy. Based on these data we can determine the coordinates of measuring and stimulation accurately so that finally we can implement patient-individual therapy.”

CorTec’s Brain Interchange technology will implement the results of the joint project. The closed-loop implant system can record and stimulate in long-term application. Thus, it enables communication between the nervous system and artificial intelligence – the starting point for the development of innovative personalized therapies.

 

Learn more about the MR-Implant project

Learn more about CorTec’s Brain Interchange System

Neuere Artikel »